ADRx, Inc.
Biotechnology ResearchCalifornia, United States2-10 Employees
ADRx, Inc. is a preclinical biotechnology company based in Thousand Oaks, California (address: 515 Marin Street Suite 314, Thousand Oaks, California 91360, United States) with a small staff of 2 to 10 employees. The company develops small molecule disaggregators and inhibitors using proprietary structure-based technology to target misfolded proteins implicated in neurodegenerative diseases. Its product pipeline includes programs targeting tau, TDP-43, and alpha-synuclein. ADRx operates in the biotechnology research industry. Financial information indicates revenue in the range of $1 million to $10 million and total funding of about $12 million.